Intrinsic Muscle Clock is Necessary for Musculoskeletal Health
Elizabeth
Introduction
Maintenance of circadian rhythms is emerging as an important new factor in human health with disruptions linked to aging as well as to the development of many chronic diseases including diabetes, cardiovascular disease, depression, and cancer. (Rajaratnam & Arendt, 2001 ) The molecular mechanism responsible for generating circadian rhythms is a conserved gene regulatory network composed of transcriptional-translational feedback loops referred to as the molecular clock. (King & Takahashi, 2000; Bmal1, a member of the PAS-bHLH family of transcription factors, encodes a core component of the molecular clock. It is now clear that the molecular clock mechanism exists in all cells in the body and can function in a cell autonomous manner. (Yoo et al., 2004; Schibler & Naef, 2005; Yamazaki & Takahashi, 2005) Studies have established that Bmal1 KO mice have a shortened lifespan, exhibit features of advanced aging, and develop cardiomyopathy and metabolic disease. (Bunger et al., 2000; Bunger et al., 2005; Kondratov et al., 2006; Antoch et al., 2008; Lefta et al., 2012) Our previous work demonstrated that skeletal muscle from Bmal1 KO mice exhibited significant weakness with decreased maximum specific tension at the whole muscle and single fiber levels at 12-14 weeks of age. We also demonstrated structural pathology with altered myofilament architecture and abnormal mitochondrial volume and function. (Andrews et al., 2010) The circadian transcriptome in skeletal muscle was first reported by Miller and colleagues in 2007 . Our lab followed this work and identified ~215 mRNAs as circadian in expression in the gastrocnemius (GTN) of wild type (WT) C57Bl6 mice including known core molecular clock components Bmal1, Per2 and Cry1. We also identified several skeletal muscle enriched genes as circadian in expression including, Myod1, Ucp3 and Myh1, which suggested the potential for links between the molecular clock and muscle homeostasis. (McCarthy et al., 2007) Studies that employed more frequent tissue sampling (every 2 hours for 48 hours) have provided greater statistical power and temporal resolution of circadian mRNA expression. This work revealed that the numbers of mRNAs exhibiting a circadian pattern in skeletal muscle is greater than 800. (Pizarro et al., 2013; Hodge et al., 2015) In addition to these gene expression findings, studies have characterized the muscle clock in development, disease and aging. (Piovezan et al.; Chatterjee et al., 2013) The most recent research utilizing skeletal muscle specific models of molecular clock disruption have focused on metabolic effects. (Dyar et al., 2014; Hodge et al., 2015)
The goal of this study was to test whether the endogenous clock in skeletal muscle is necessary for the maintenance of adult skeletal muscle phenotype and function. We generated an inducible line of mice in which Bmal1 is deleted only in adult skeletal muscle following tamoxifen treatment (iMSBmal1 -/-). Remarkably, at the time of collection, histological examination and functional measures revealed a similar phenotype to that observed in the germline Bmal1 KO mice.
The phenotype observed in the iMSBmal1 -/-mice was not limited to changes in muscle quality.
Similar to the Bmal1 KO mice, we observed significant bone and cartilage changes throughout the body. This emerging area of circadian rhythms and the molecular clock in skeletal muscle holds potential to provide significant new insights into mechanisms of age associated muscle weakness and the potential for novel therapeutic strategies for treatment.
Methods

Ethical approval
All animal procedures were conducted in accordance with institutional guidelines for the care and use of laboratory animals as approved by the AAALAC accredited, University of Kentucky Institutional Animal Care and Use Committees.
General experimental approaches
No data points, samples or mice were excluded from the study. Animals were randomized as stated below for vehicle or tamoxifen treatment.
Mouse model
The floxed Bmal1 mouse was purchased from Jackson laboratories and has no reported breeding, physical or behavioral abnormalities. (Storch et al., 2007) The skeletal muscle-specific Crerecombinase mouse (HSA-Cre) was generated in house. (Hodge et al., 2015) C57BL/6J (Jackson Laboratory) and Bmal1 −/− mice (Bmal1 KO), 20-22 weeks of age, were used in the current study. (Andrews et al.) It is important to note that the wild type mice used in this analysis are littermates of the Bmal1 KO mice because the Bmal1 KO mice are sterile so all breeding was done with the Bmal1 +/-mice. All experimental mice were housed in a temperature-and humidity-controlled custom light boxes maintained on a 12-hour light-12 hour dark cycle with food and water ad libitum. The cardiac specific Bmal1 KO mouse (iCSΔBmal1) has been characterized previously. (Schroder et al., 2013) 
Circadian Collections
Forty-eight iMSBmal1 mice were housed in cages in light boxes and entrained to a 12 hour light: dark cycle for 14 days. Mice had ad libitum access to food and water. Following the two week entrainment period, 24 mice, 12-16 weeks of age, were injected with vehicle and 24 with tamoxifen for five consecutive days, generating 24 iMSBmal1 +/+ and 24 iMSBmal1 -/-mice respectively. The light schedule was kept the same during injections and for the subsequent five weeks. After the last normal dark cycle at 5 weeks, lights were not turned on so the mice were housed in constant darkness. Tissue collections were started after 30 hours of darkness and mice were sacrificed by cervical dislocation under dim red light. Once the mice were dead, we cut neural connections from the eyes to the retinohypothalamic tract to make sure no light would be received once lights were turned on for dissection of tissues. Gastrocnemius muscles, heart, and liver were collected every four hrs for 28 hrs (6 time points) and flash frozen in liquid N 2 for RNA and protein analysis.
RNA isolation and real time PCR
Total RNA was prepared from frozen tissue samples using TRIzol (Invitrogen) according to the manufacturer's directions. RNA samples were treated with TURBO DNase (Ambion) to remove genomic DNA contamination. Isolated RNA was quantified by spectrophotometry (λ = 260 nm). First-strand cDNA synthesis from total RNA was performed with a mixture of oligo (dT) primer and random hexamers using SuperScript III First-Strand Synthesis SuperMix (Invitrogen). All isolated RNA and cDNA samples were stored at -80°C until further analysis. Real-time quantitative PCR using TaqMan (Applied Biosystems) assays was used to examine the gene expression of core-clock and clockcontrolled genes. RPL26 was used as the internal calibration control. The ∆∆CT method was used for the quantification of real-time PCR data in the circadian collections. Gene expression in each sample was shown as the relative value compared to the mean vehicle value in that tissue (gastrocnemius (GTN)). Microarray sample preparation and analysis has been described previously. (Hodge et al., 2015) Immunohistochemistry Vehicle and tamoxifen treated iMSBmal1 mice were sacrificed by cervical dislocation and tibialis anterior muscles (TA) were collected at 58 weeks post-treatment. 
Muscle Function
Immediately following cervical dislocation, the EDL muscle was dissected free and removed for measures of maximum isometric tetanic force from wild type (n = 5), Bmal1 -/-(n = 6) and iMSBmal1 +/+ (n = 5), iMSBmal1 -/-(n = 5), and iCSΔBmal1 -/-(n = 3). Braided silk suture (4-0) tethers were tied to the extensor digitorum longus (EDL) at the proximal and distal tendons before the EDL was excised from the leg. The distal end was attached to a platinum wire hook inside a temperature-controlled muscle bath (Radnoti) containing oxygenated Krebs-Ringer solution (137mM NaCl, 5mM KCl, 1mM MgSO 4 , 1mM NaH 2 PO 4 , 24mM NaHCO 3 , and 2mM CaCl 2 ) perfused with 5% CO2-95% O2 at a pH between 7.25 and 7.35 at room temperature. The other end was attached to an Aurora 300C-LR lever arm (ASI). The muscle was positioned between platinum electrodes and subjected to electrical field stimulation (supramaximal voltage, 0.5ms pulse duration) using an Aurora 701C stimulator. Force output was measured and recorded using ASI 610A Dynamic Muscle Control software. Optimal length (Lo) was determined by adjusting the EDL position to maximize twitch force at 1Hz and length was measured with digital calipers. Bath temperature was then increased to 37°C, and the muscle was permitted to warm up for 30 min. Curare (D-tubocurarine, 25uM) was added after 25 minutes. The force-frequency relationship was determined using contractions at 2-min intervals with stimulus frequencies of 1, 15, 30, 50, 80, 120, 150, 250, and 300 Hz and a tetanic pulse duration of 500 ms. Maximal tetanic contractions were stimulated at 300Hz between lower-frequency contractions to monitor the change in maximal force over time, an index of stability. After each experiment, the muscle was removed from the apparatus, gently blotted dry, and weighed. Physiological cross-sectional area was estimated according to Brooks and Faulkner (1988) (Brooks & Faulkner, 1988 ) and used to calculate specific force.
Myosin Heavy Chain Gels
Mice were sacrificed by cervical dislocation and plantaris muscles from Bmal1 KO (22wks old) and age matched wild type, or iMSBmal1 -/-and iMSBmal1
(58 weeks posttreatment) were homogenized using 60 volumes of extraction buffer (50 mM Tris-HCl, pH 8.8, 10% glycerol containing 2% SDS). (Biesiadecki et al., 2004) Diaphragm was used as control sample for visualizing different myosin heavy chain (MHC) isoforms. Samples were heated at 80°C for 5 min and spun at high speed for 5 min to remove debris. Protein concentration was measured, and samples were diluted with dilution buffer (0.38M Tris-HCl, pH6.8, 2% SDS, 25mM DTT, 0.02% bromophenol, 15% glycerol) to 0.1ug/ul. 0.75 ug protein per sample was resolved by SDS-PAGE gel prepared as described previously. (Talmadge & Roy, 1993) The gels were run at 4C with an initial voltage of 70V.
After 2 hrs, voltage was increased to 100V. Total time for running the gel was 32 hrs. MHC isoforms were developed using a Silver stain kit (Bio Rad).
Gait Analysis
Mice were anesthetized in an induction box using 5% isoflurane, 1L/min oxygen), then maintained at 1.5% isoflurane and 500L/Min oxygen via a nose cone. Hair on the hind limbs was removed using Nair™. This was performed at least 24 hours prior to gait analysis. Mice were placed in the first lane of a motorized walkway (EXER 3/6 treadmill, Columbus Instruments, Columbus, OH) and sagittal plane movements were recorded for two minutes at 250 frames/sec (HotSHot Camera, NAC Image Technology, Simi Valley, CA, USA) to assure accurate delineation of stance and swing phases during each gait cycle. Following the recording session, mice were returned to their cages (Supplementary Videos 1-4). These mice were sacrificed approximately 10 weeks later by cervical dislocation and were included in the cohort of mice used for the bone staining protocol.
Digital image data were manually selected and extracted from the video data for seven to ten consecutive gait cycles at the moment the paw made contact and lost contact with the treadmill to calculate stance and swing phase durations during gait. Additional images were extracted during the swing and stance phases to measure maximal active dorsiflexion of the ankle and maximal passive extension of the metatarsal-phalangeal (MTP) joints of the forefoot, respectively. Digital images were transferred to a digital microscope and imaging system (VHX-600, Keyence Corporation, Itasca, IL, USA) and line-segments were created for the femur, tibiofibula, foot, and phalanx segments.
Bone Staining
Hind limbs for Alizarin Red/Alcian Blue staining were collected from 58 weeks posttreatment iMSBmal1 +/+ and iMSBmal1 -/-mice and muscle and connective tissue were removed.
Bones were fixed in 95% ethanol for 1-2 days. They were then rocked at 37°C in Alcian Blue/Alizarin
Red stain for 3-4 days. Following staining they were rinsed 1 time in ddH 2 O and then transferred to 1% KOH. They were rocked at room temperature for a minimum of 3 hours. 1% KOH was replaced and rocking continued overnight at room temperature. Depending on the intensity of the stain and the amount of tissue remaining on the bone additional KOH washes were performed as needed.
They were then rocked for 24 hours each in the following glycerol/KOH washes: 20% glycerol/1% KOH (24 hours at room temperature on rocker); 50% glycerol/1% KOH (24 hours at room temperature on rocker); 80% glycerol/1% KOH (24 hours at room temperature on rocker). Bones were stored and photographed in 80% glycerol/1% KOH solution at room temperature.
Statistical Analysis
Results are reported as mean ± SEM. For comparison of 1 parameter between 2 strains of mice, statistical analysis was performed using 2-tailed, unpaired Student's t test. A two-way ANOVA was used to determine a significant interaction between factors (strain and time). If a significant interaction was detected, a Bonferonni post-hoc comparison was performed. P < 0.05 was considered significant. Statistical analysis was performed with Graphpad Prism software. Circadian analysis was performed using JTK_cycle. (Hughes et al., 2010) Results
Characterization of the mouse model.
Our early studies of muscle in the Bmal1 KO mouse provided evidence to support links between disruption of circadian rhythms, the molecular clock and muscle function. However, these mice are disrupted in all cell types so they do not allow us to discern the relative contribution of the skeletal muscle clock to muscle function and weakness. To address the function of the molecular clock in skeletal muscle we generated an inducible muscle specific Bmal1 knock out mouse for the targeted disruption of the molecular clock mechanism only in adult skeletal muscle. (Hodge et al., 2015) We carried out a circadian time course collection with vehicle and tamoxifen-treated mice.
GTN from iMSBmal1
+/+ and iMSBmal1 -/-mice were collected every 4 h over a 28-h period, RNA was extracted, and microarray assessment and real-time PCR were performed to evaluate the function of the molecular clock. The time course collection allowed us to identify the mRNAs exhibiting a circadian pattern and extract quantitative data about the amplitude (difference between peak and mean value for the waveform) of the oscillation using JTK_cycle. (Hughes et al., 2010) As depicted in the heat map in Fig. 1 , we identified 629 non-redundant mRNAs that exhibit a circadian pattern of expression in the GTN of vehicle treated mice. In contrast, loss of Bmal1 from skeletal muscle resulted in a significant disruption in almost every gene (Fig. 1) . (Hodge et al., 2015) We performed quantitative real time PCR (qPCR) on core molecular clock genes including Per2, Cry1, Reverb, Rora, Clock and genes known to be regulated downstream of the molecular clock (i.e. clock controlled genes) including Dbp and MyoD1 to quantify the efficacy of molecular clock disruption. As expected we observed a robust, high amplitude oscillation for Bmal1 expression in the GTN of iMSBmal1 +/+ mice, which was lost in the iMSBmal1 -/-mice. The low level expression and damped amplitude of Bmal1 mRNA in the iMSBmal1 -/-mice is consistent with loss of expression in the muscle but continued expression in other non-muscle cell types in the tissue. Consistent with disruption of Bmal1, we found that the amplitudes for most of the core molecular clock genes and clock controlled genes were significantly reduced (~ 70-90%) in the iMSBmal1 -/-GTN. Mean amplitudes with calculated high and low amplitude values as error bars (JTK_cycle), as well as, the average fold change in expression over the entire time course for these genes is graphed in Fig. 2 A demonstrating significant reductions in amplitude and overall expression for the core molecular clock genes, Bmal1, Rora, and Reverbα. Expression levels of Dbp, a well characterized CCG, and
Myod1, a muscle specific CCG, (Andrews et al., 2010; Zhang et al., 2012) were significantly decreased in the GTN of the iMSBmal1 -/-mice. Clock, a component of the core molecular clock mechanism, was upregulated in response to loss of Bmal1 similar to that previously shown in the skeletal muscle. (Dyar et al., 2014) Further analysis of the array data revealed that several transcription factors well known to regulate muscle specific and fiber type gene expression were disrupted. These transcription factors included Pgc1α, Sox6, Mef2a, and Six1 (Fig. 2 B) .
Muscle Function in the iMSBmal1 and Bmal1 KO mice
The in vivo declines in human muscle strength with age and other chronic diseases can be regulated at many levels including changes in size, motor unit recruitment, innervation and excitation contraction coupling. (Brooks & Faulkner, 1994; D'Antona et al., 2003; Delbono, 2003; Morse et al., 2005; Mitchell et al., 2012) Our previous work has demonstrated that muscle force per unit cross section (specific force) measured in vitro is significantly reduced in the EDL muscles/muscle fibers of the 12-14 week old Bmal1 KO mouse compared to wild type controls. (Andrews et al., 2010) In this study we used grip strength measures as a way to monitor changes in neuromuscular function in our mice. We assessed muscle function in vivo, using grip strength analysis at 55-60 weeks post-treatment and measured a reduction in forelimb grip force in the iMSBmal1 -/-compared to iMSBmal1 +/+ mice (Fig. 3 A) . Ex vivo measures of specific force in the EDL muscle demonstrated that loss of grip strength was associated with significant muscle weakness. In fact, we observed reductions in specific force in EDL muscle at both 20 and 58 weeks post-treatment ( Fig. 3 B, C) . We also found that Bmal1 KO mice have significantly reduced forelimb grip strength compared to their littermate controls at 25-40 weeks of age (Fig. 3 D) . Consistent with our previous studies of muscle function in young Bmal1 KO mice we found that specific force continued to be reduced in the EDL muscle Bmal1 KO mice at 20-22 weeks of age. However, unlike what we reported for muscle function in the 12-14 week old Bmal1 KO mice, we observed a significant leftward shift of the force frequency curve suggesting a shift toward slower fiber types in the Bmal1 KO mice in consonance with an aging muscle phenotype. (Tikunov et al., 2001; Chan & Head, 2010) (Fig. 3 E) . In contrast to the iMSBmal1 -/-, skeletal muscle from aged mice in which
Bmal1 is knocked out only in cardiomyocytes, (iCS∆Bmal1 -/-) (Schroder et al., 2013) revealed no changes in EDL specific force (Fig. 3 F) . The results from the iCS∆Bmal1 -/-mouse demonstrate that the functional effects we report are not due to the 5 day tamoxifen treatment and are specific to loss of Bmal1 in skeletal muscle and not another striated muscle tissue.
A well-known feature of aging in skeletal muscle is a shift in fiber type characterized by a decrease in the Type IIB fibers with increases in the more oxidative Type IIA fibers. (Ciciliot et al., 2013; Miller et al., 2014; Purves-Smith et al., 2014; Miljkovic et al., 2015) (Fig. 4 B) . Myosin heavy chain gels of plantaris muscle quantitatively confirm increased expression of Type IIa myosin heavy chain (Fig. 4 C) . This shift toward a more oxidative fiber type is consistent with that observed in the Bmal1 KO. Significant decreases in the number of Type IIX fibers with concomitant increases in Type IIA fibers were observed in the TA from the Bmal1 KO muscle (Fig. 4 D) . Figure 4 E shows representative images of SDH staining in the TA muscle from wild type and Bmal1 KO mice at 22 weeks of age. The percent SDH positive fibers was significantly increased in the Bmal1 KO muscle. As with the iMSBmal1 -/-mice, myosin heavy chain gels confirmed the fiber type shift (Fig. 4 F) . These changes in fiber type occurred without a change in cage activity (Hodge et al., 2015) and with no change in fiber cross sectional area (1265±23.08 mm 2 iMSBmal1 +/+ (n=6); 1224±62.58 mm 2 iMSBmal1 -/-(n=5)) or the number of centrally nucleated fibers in the TA of iMSBmal1 -/-mice as shown in representative hematoxylin and eosin (H&E) images (Fig. 5 A) . However, in concordance with the previously demonstrated advanced aging phenotype, hematoxylin and eosin (H&E) stained tibialis anterior (TA) muscle from wild type and Bmal1 KO mice revealed an increased number of centrally nucleated fibers and a decreased average fiber area in Bmal1 KO compared to wild type muscle at 22 weeks of age. The summary data for the image analysis (n=5) are provided in Fig. 5 B.
Fibrosis and Skeletal phenotype in iMSBmal1 -/-and Bmal1 KO mice
One common feature in models of muscle weakness, including dystrophies, myopathies and aging, is that increased fibrosis is often observed in muscle concomitant with the reduction in specific force as extracellular matrix components accumulate. Consistent with these observations we found an increased interstitial staining with WGA in the iMSBmal1 -/-mice (Fig. 6 A) . We detected more fibrosis in the muscle of iMSBmal1 -/-mice when compared to the Bmal1 -/-mouse (Fig. 6 B) .
We next asked whether the weakness and increased fibrosis seen in the iMSBmal1 -/-muscle was associated with diminished satellite cell number. In contrast to what is seen with aging, Fig. 6 C shows no significant changes in PAX7 positive nuclei per muscle fiber in the TA of the iMSBmal1
mice. This is in contrast to the reduced PAX7 staining in the Bmal1 KO TA that shows a significant reduction in satellite cell number (Fig. 6 D) .
To evaluate potential factors that could contribute to the observed increases in fibrosis, we examined our microarray data from the GTN of the iMSBmal1 +/+ and iMSBmal -/-mice for changes in extracellular matrix components. The microarray data is measured at 5 weeks post treatment and at that time we observe significant increases in the mRNA expression for collagens 4 (Col4) and 6 (Col6), and a trend toward increase for collagen 1 (Col1) (p=0.057). Extra cellular matrix components including the proteoglycan, perlecan (Hspg2), as well as, agrin (Agrn) and dystroglycan (Dag1) were also significantly increased at this time point suggesting that signaling involved in the development of fibrosis begins shortly after loss of Bmal1 in the skeletal muscle. (Fig. 7 A) In addition, we used the microarray data to examine markers of fibroblasts in skeletal muscle. This analysis revealed increases in the mRNA expression of several fibroblast specific markers including Tcf-4, scleraxis (Scx), Fgf1 and the Fgf1 receptor (Fgf1r). (Fig. 7 B) Lastly we found changes in the mRNA expression of components of the Wnt signaling pathway (e.g. Frzb, Lrp1), as well as, components of the Tgfß superfamily (e.g.Tgfb1, Mstn) in the microarray data from the iMSBmal1 -/-mice. Future studies are needed to determine the mechanism(s) through which loss of Bmal1 only in muscle fibers contributes to significant changes impacting ECM formation and remodeling. (Fig. 7 C) One of the more striking phenotypes was the overall outward appearance of the iMSBmal1 -/-mice. As can be seen in Fig. 8 A, iMSBmal1 -/-displayed loss of hair, increased prevalence of dermatitis, kyphosis, as well as tail and ear morphological abnormalities. Because of the close proximity of skeletal muscle with bone and the known arthropathy reported in the Bmal1 -/-mice, we asked whether there was any bone phenotype in the iMSBmal1 -/-mice. Fig. 8 Fig. 8 B) , reduced cartilage staining in the foot/ankle and the appearance of flattened tarsals and misshapen tibia and fibula. We also found that changes in the skeletal system
were not limited to the limbs as we observed increased calcification and diminished cartilage staining throughout the rib cage and thoracic spine (Fig. 8 C) . The arthropathy observed in the iMSBmal1 -/-is similar to that observed in the germline Bmal1 KO mice indicating that loss of Bmal1 only in skeletal muscle is sufficient to induce this severe skeletal system pathology ( Fig. 8 D, 
E).
Changes in muscle function and muscle and bone phenotype suggested potential impacts on gait. We performed gait analysis using high speed videography with mice walking on a flat treadmill.
In our studies mice were forced to walk at a given pace on a treadmill but the pace selected was not faster than the slowest mouse could maintain during the recording. Biomechanical analysis of the iMSBmal1 -/-mice revealed significant reductions in both ankle and metatarsophalangeal range of motion ( Table 1) at toe-off, common in joint pathology (Supplemental Video 1, 2). They also had significant reductions in swing time and stride length. Similar disruptions in gait were present in the Bmal1 KO mice ( Table 2 , Supplemental Video 3, 4).
Discussion
The recognition that the molecular clock mechanism exists in virtually all cells, including skeletal muscle, combined with the knowledge that peripheral clocks can be modulated independent of the central clock has raised significant questions about the role of the molecular clock in peripheral tissues. Genetic mouse models have provided a means to disrupt the molecular clock in a tissue/cell specific manner in order to mechanistically address the contribution of the clock to tissue/cell function with the potential to examine larger effects on systems health. (McDearmon et al., 2006; Hughes et al., 2012; Paschos et al., 2012; Su et al., 2012; Schroder et al., 2013) Novel data presented in this paper provide evidence demonstrating the importance of the intrinsic skeletal muscle molecular clock in regulating maintenance of muscle function and phenotype. Our findings are also exciting as they uncover a fundamental role for skeletal muscle molecular clock in skeletal homeostasis. We show that loss of Bmal1 in adult skeletal muscle leads to a decrease in specific tension that is evident by 20 weeks along with a shift toward a more oxidative fiber type and increases in muscle fibrosis. These properties of skeletal muscle are changing in the absence of changes in muscle mass and were not associated with behavioral changes in feeding or cage activity. (Hodge et al., 2015 ) Surprisingly, the phenotype observed in the iMSBmal1 -/-mice was not limited to changes in skeletal muscle. Similar to the germline Bmal1 KO mice, we observed significant bone and tendon/cartilage changes throughout the body. Thus, our findings implicate the endogenous skeletal muscle molecular clock as a modulator of musculoskeletal health.
The observed changes in muscle phenotype and function occurred in the absence of changes in physical activity or feeding. (Hodge et al., 2015) Thus, they were directly downstream of disruption of the molecular clock machinery in adult muscle. One potential mechanism for changes in fiber type and phenotype could be through altered expression of transcription factors linked to muscle gene expression. It is well established that molecular clock factors bind to many sites across the genome. (Atwood et al., 2011; Koike et al., 2012; Korenčič et al., 2014; Yoshitane et al., 2014) In addition, circadian transcriptome studies have suggested that the clock factors target the expression of many transcription factors. (McCarthy et al., 2007; Andrews et al., 2010; Khapre et al., 2010; Mazzoccoli et al., 2012; Zhang et al., 2012) Analysis of our microarray time series (Hodge et al., 2015) as well as real time PCR studies demonstrated that loss of Bmal1, in addition to disruption of the core clock mechanism, resulted in significant decreases in expression of a number of transcription factors important in regulating skeletal muscle phenotype and function including MyoD1, Sox6, Mef2a, Six1, as well as the transcriptional co-activator Pgc1α. (Yablonka-Reuveni & Rivera, 1997; Dunn et al., 2000; Andrews et al., 2005; Quiat et al., 2011; Richard et al., 2011; Zhang et al., 2012; Khodabukus & Baar, 2015) We propose that daily expression of Bmal1 targets these transcription factors for maintenance of a myogenic program of gene expression. It is important to note that not all transcription factors exhibit a circadian pattern in skeletal muscle. For example both Pgc1α and Mef2a are not expressed in a circadian manner in skeletal muscle but are significantly down-regulated following loss of Bmal1. (Pizarro et al., 2013; Hodge et al., 2015) Future studies examining the mechanism of clock control for these muscle transcription factors will provide exciting new insight into mechanisms through which muscle enriched and fiber type specific protein expression is maintained in vivo.
In this study we observed decreased muscle function at both 22 and 58 weeks posttreatment and a shift toward a more oxidative fiber type at 58 weeks post treatment in the iMSBmal1 -/-mice. Our results are in contrast to recent work using a similar inducible muscle specific Bmal1 KO model which did not observe significant changes in fiber type composition or loss of force production. (Dyar et al., 2014) We have analyzed several different generations of mice and we have performed a thorough analysis of recombination specificity with important downstream molecular clock analysis providing confidence in our findings. (Hodge et al., 2015) Thus, we believe that the contrasting outcomes between our studies are likely due to two differences in experimental design.
Specifically, we treated our mice with tamoxifen for Bmal1 recombination between the ages of 12-16 weeks of age. We chose this age because it is beyond the age of rapid skeletal muscle growth during post-natal maturation. (Quinlan et al., 1997; Harrison, 2011) This maturational growth is associated with satellite cell fusion so would effectively dilute the Bmal1 -muscle fibers through addition of Bmal1 + nuclei after the tamoxifen treatment. Recombination in the Dyar paper was induced at 8 weeks. The second difference between our studies is that we completed the primary functional and histological studies at 58 weeks post-treatment compared to the 5 months/20 weeks reported in the Dyar studies.
Satellite cells, the primary resident stem cell in skeletal muscle, are required for regeneration and repair and numbers diminish with age. (Montarras et al., 2013; Rai et al., 2014) Quiescent satellite cells express the transcription factor PAX7 which is subsequently down regulated upon satellite cell activation. (Chang & Rudnicki, 2014) In accordance with the demonstrated advanced aging phenotype of the Bmal1 KO mice we saw a reduction in the number of satellite cells per muscle fiber in the TA, however, no significant differences were observed the in the iMSBmal1
-/-mice. Disparities between the iMSBmal1 -/-and Bmal1 KO mice suggest that the presence of Bmal1 in the satellite cell, or timing of Bmal1 expression in the satellite cell during development, or both may regulate satellite cell number. More importantly, in the iMSBmal1 -/-mice, the observed muscle weakness and increased fibrosis are not due to any changes in satellite cell number and therefore, indicate that this phenotype originates from the loss of Bmal1 within the muscle fiber. This observation is consistent with the recent findings by (Fry et al., 2015) that satellite cells did not contribute to the maintenance of muscle size or fiber type composition during aging.
Muscle and bone are intimately linked through growth and development, mechanical load, endocrine function, and genetic pleiotropy. (Curtis et al., 2015) Our findings presented are the first to demonstrate a fundamental and direct muscle to bone interaction that occurs not due to development but in an adult animal. The systemic increases in bone/ tendon calcification in the presence of a functionally weak skeletal muscle, appears to be a unique finding to mice in which circadian rhythms/molecular clock is disrupted. (Bunger et al., 2005; Maronde et al., 2010) However, those studies use mice in which molecular clock components are disrupted in all cell types. Our study clearly defines that loss of Bmal1/molecular clock function only in skeletal muscle is sufficient to induce skeletal remodeling in the presence of normal molecular clock components across nonskeletal muscle tissue. The other unusual observation is that most models of muscle weakness are associated with decreased bone calcification. (Morissette et al., 2009; Arounleut et al., 2013; Isaac et al., 2013) This suggests that the observed changes in bone (increased calcification) in our mouse model are not due to altered mechanics but more likely the result of changes in circulating factors from the iMSBmal1 -/-muscle influencing gene expression/function in bone and thus, effecting remodeling.
The role of muscle as an endocrine organ is becoming more widely recognized in the field. (Iizuka et al., 2014; Catoire & Kersten, 2015) Our findings suggest that loss of Bmal1 in skeletal muscle leads to significant changes in the endocrine/paracrine function of muscle with implications for cartilage, tendon and bone. The gene expression results implicate the WNT signaling pathway which has been established to lead to a disruption of both bone and skeletal muscle. (Tzahor et al., 2003; Wagers, 2008; Scimè et al., 2010; Tompkins, 2011; von Maltzahn et al., 2012; Zhang et al., 2014) We also observed changes in the expression of several secreted proteins in the Tgfβ family, which may act in a paracrine fashion in the musculoskeletal niche and are known to impact bone.
These include Tgfß1, Tgfß2 and Tgfß3 (Figure 7 C) . (Kawao & Kaji, 2015) Important in bone remodeling, they are responsible for complex interactions involved in coupling bone formation and resorption. In addition, expression of myostatin (Mstn), a well-known muscle specific Tgfβ family member, is significantly decreased in the GTN of the iMSBmal1 -/-mice. Mice with a global knockout of Mstn show increased bone density. (Elkasrawy & Hamrick, 2010) Thus, future studies using tissue specific targeting of both WNT and TGF signaling pathways will be critical for understanding their role in the muscle to bone remodeling seen in the iMSBmal1-/-mice.
Gait disorders generally have multiple origins and tend to be related to underlying medical conditions. However, there are several hallmarks of an aging gait, including a reduction in gait velocity and stride length, increased stance width and time, and reduced force development at push off. (Ostir et al.; Aboutorabi et al., 2015) The observed changes in muscle function and muscle and bone phenotype in the Bmal mice have measurable impacts on gait which mimic that observed in the aging human population including reductions in stride length and swing time, as well as, loss of range of motion in the joints of the ankle and foot. Although not measured, based on assessed parameters, as well as, video observation the chosen gait velocity for the knockouts would have been significantly slower consistent with human aging.
Our findings provide new insight into the fundamental role of the endogenous molecular clock in skeletal muscle homeostasis and uncover the broader function of the skeletal muscle molecular clock in musculoskeletal health. These findings provide a foundation for the inclusion of skeletal muscle assessment and development of targeted therapeutic strategies to "reset" the muscle clock in aging and disease in order to promote musculoskeletal health. 
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